In silico veritas? Potential limitations for SARS-CoV-2 vaccine development based on T-cell epitope prediction

PLoS Pathog. 2020 Jun 4;16(6):e1008607. doi: 10.1371/journal.ppat.1008607. eCollection 2020 Jun.

Sandra Silva-Arrieta¹, Philip J R Goulder^{2

3

4}, Christian Brander^{1

5

6}

¹ IrsiCaixa AIDS Research Institute, Hospital Germans Trias i Pujol, Institute for Health Science Research Germans Trias i Pujol (IGTP), Badalona, Spain.
² Department of Paediatrics, University of Oxford, Oxford, United Kingdom.
³ HIV Pathogenesis Programme, The Doris Duke Medical Research Institute, University of KwaZulu-Natal, Durban, South Africa.
⁴ Ragon Institute of MGH, MIT, and Harvard, Cambridge, Massachusetts, United States of America.
⁵ University of Vic-Central University of Catalonia, Catalonia, Vic, Spain.
⁶ Catalan Institution for Research and Advanced Studies (ICREA), Barcelona, Spain.

No abstract available

Publication types